
    
      Hydroxychloroquine will be administered preoperatively to 30 patients undergoing cardiac or
      noncardiac surgery. All patients will undergo magnetic resonance imaging (MRI) with
      gadolinium in the post-operative period before hospital discharge in order to assess blood
      brain barrier permeability.
    
  